Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Artículo en Chino | WPRIM | ID: wpr-928359

RESUMEN

OBJECTIVE@#To analyze the clinical phenotype and genetic characteristics of a child with Perlman syndrome.@*METHODS@#Genomic DNA was extracted from peripheral blood samples from the patient and her parents. Whole exome sequencing (WES) was carried out to detect potential variant in the proband. Candidate variant was verified by Sanger sequencing. The pathogenicity of candidate variants was evaluated according to the guidelines of the American College of Medical Genetics and Genomics (ACMG).@*RESULTS@#The results of WES showed that the proband has harbored compound heterozygous variants of the DIS3L2 gene, namely c.2109delC and c.1829.c.1830insC, which were respectively inherited from her mother and father. The results were confirmed by Sanger sequencing. Based on the ACMG guidelines, the two novel variants were both predicted to be pathogenic (PVS1+PS2+PM2).@*CONCLUSION@#The compound heterozygous variants of the DIS3L2 gene probably underlay the Perlman syndrome in this patient. Above finding has enriched the spectrum of DIS3L2 gene mutations.


Asunto(s)
Femenino , Humanos , Exorribonucleasas , Macrosomía Fetal , Pruebas Genéticas , Genómica , Mutación , Secuenciación del Exoma , Tumor de Wilms
2.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;48(1): 44-49, jan-feb/2015. tab
Artículo en Inglés | LILACS | ID: lil-742974

RESUMEN

INTRODUCTION: In 2010, to reduce the occurrence of serious pneumococcal disease, the Ministry of Health in Brazil incorporated the 10-valent pneumococcal vaccine in the immunization schedule of children younger than two years of age. The objective of this study was to evaluate the impact of vaccination on the incidence of infectious respiratory diseases in infants before and after the introduction of the 10-valent pneumococcal vaccine. METHODS: This cross-sectional study involved primary care and hospital networks from a city in Minas Gerais State, Brazil, between 2009 and 2012. RESULTS: A 40% reduction in the prevalence of community-acquired pneumonia (CAP) was observed after introducing the pneumococcal conjugate vaccine. Male children were 28% more likely to develop the disease. The prevalence ratio ([PR] = 1.96, 95% CI: 1.52 to 2.53, p < 0.05) suggested that not being vaccinated was associated with the occurrence of pneumonia. The prevalence of CAP was 70% lower (PR 0.30, 95% CI: 0.24 to 0.37, p<0.05) in children vaccinated as recommended compared to children with delayed vaccination, suggesting that the updated vaccine schedule improves protection. CONCLUSIONS: Immunization with the 10-valent pneumococcal vaccine appeared to reduce the number of pneumonia cases in children during the study period. Prospective studies are needed to confirm the efficacy of the vaccine against the occurrence of pneumococcal pneumonia. .


Asunto(s)
Humanos , VIH-1 , ARN Mensajero/metabolismo , ARN Viral/metabolismo , Proteínas de Unión al ARN/metabolismo , Empalme Alternativo , Western Blotting , Endorribonucleasas/genética , Endorribonucleasas/metabolismo , Exorribonucleasas/genética , Exorribonucleasas/metabolismo , VIH-1 , Interacciones Huésped-Patógeno , Inmunoprecipitación , Unión Proteica , Interferencia de ARN , ARN Mensajero/genética , ARN Viral/genética , Proteínas de Unión al ARN/genética , Transactivadores/genética , Transactivadores/metabolismo
3.
Artículo en Chino | WPRIM | ID: wpr-355805

RESUMEN

<p><b>OBJECTIVE</b>To analysis the molecular interaction network of 14-3-3 sigma in non small cell lung cancer (NSCLC) cells.</p><p><b>METHODS</b>Established stable over-expressed 14-3-3 sigma protein PG cells, MTT assay was used to assess the growth rate of PG cells. Though stable isotope labeling by amino acids in cell culture (SILAC) and Mass spectrometry (MS) technology, to identify difference expressed proteins caused by over expressed 14-3-3 sigma. The protein expressed >2 or <0.5 times was termed as the differential protein. By searching Human protein reference database (HPRD) and Kyoto encyclopedia of genes and genomes (KEGG), established the molecular interaction network of tumor suppressor gene 14-3-3 sigma.</p><p><b>RESULTS</b>The growth rate of over-expressed 14-3-3 sigma PG cell was obviously slower down compared to vector PG cells. A database including 147 differential protein was established. And a molecular interaction network of 14-3-3 sigma containing 26 protein was constructed.In this network, the expression of CSNK2A1 (casein kinase II subunit alpha), involved in numerous cellular processes, such as cell cycle progression, apoptosis and transcription, was the most significantly increased. A DNA repair protein, MEN1 (Menin) which functions as a transcriptional regulator was the most significantly decreased.</p><p><b>CONCLUSION</b>After stable transfected with 14-3-3 sigma gene, growth rate of PG cells was inhibited, the proteins associated with cell cycle, DNA damage repair mechanisms were significantly changed, and constructed the molecular interaction network.</p>


Asunto(s)
Humanos , Proteínas 14-3-3 , Genética , Aminoácidos , Biomarcadores de Tumor , Genética , Carcinoma de Pulmón de Células no Pequeñas , Genética , Ciclo Celular , Línea Celular Tumoral , Proliferación Celular , Exorribonucleasas , Genética , Marcaje Isotópico , Métodos , Neoplasias Pulmonares , Genética , Espectrometría de Masas , Transfección
4.
Artículo en Chino | WPRIM | ID: wpr-259306

RESUMEN

<p><b>OBJECTIVE</b>To investigate the expression of 14-3-3 sigma and heat shock protein 27 (HSP27) in colorectal carcinoma(CRC) tissue and its clinical significance.</p><p><b>METHODS</b>The expression of 14-3-3 sigma and HSP27 was detected by immunohistochemical staining in 50 pathologically verified CRC cases. The association of clinical data with 14-3-3 sigma and HSP27 expression was examined.</p><p><b>RESULTS</b>The positive expression rate of 14-3-3 sigma was 10% in normal control mucosa and 58% in CRC tissue (P<0.01). The positive expression rate of HSP27 was 16% in normal control mucosa and 54% in CRC tissue (P<0.01). No correlation between 14-3-3 sigma and HSP27 expression was found in CRC tissue (P>0.05). The expression of 14-3-3 sigma was associated with patient age, tumor diameter and lymph node metastasis (LNM) (P<0.05), but not with gender, tumor differentiation or serous membrane invasion (P>0.05). The expression of HSP27 was associated with LNM (P<0.05), but not with gender, age, differentiation, tumor diameter or serous membrane invasion (P>0.05).</p><p><b>CONCLUSION</b>The abnormal expression of 14-3-3 sigma and HSP27 is significantly associated with LNM in CRC.</p>


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Proteínas 14-3-3 , Biomarcadores de Tumor , Metabolismo , Neoplasias Colorrectales , Metabolismo , Patología , Exonucleasas , Metabolismo , Exorribonucleasas , Proteínas de Choque Térmico HSP27 , Metabolismo , Metástasis Linfática , Proteínas de Neoplasias , Metabolismo
5.
Artículo en Chino | WPRIM | ID: wpr-343874

RESUMEN

The purpose of this study was to establish a SYBR Green I real-time quantitative RT-PCR method for investigating the correlation between CML28 mRNA expression levels and relapse of leukemia after allo-hematopoietic stem cell transplantation (HSCT). pcDNA3.1HisA-CML28 plasmid had been constructed as the standard template. Serial monitoring of CML28 mRNA levels by SYBR Green I real-time quantitative RT-PCR technique was performed in 14 patients, including 10 patients with CML and 3 patients with AML, 1 patient with Ph(+) ALL. The results showed that the sensitivity of the established method was at 10(-4) (0.05 ng) level, with interassay variation and intraassay variation of standard samples both below 10%. The CML28 was highly expressed in AML and CML-BP or AP. CML28 level in newly diagnosed group was (6.58 +/- 2.34) x 10(-2), in pre-conditioning regimen group was (2.19 +/- 0.32) x 10(-2), in group that 1 month after HSCT was (1.35 +/- 1.28) x 10(-2), in group that 3 months after HSCT was (4.57 +/- 6.39) x 10(-3). CML28 can be detected 3 months after HSCT in 1 patient with CML-CP and 3 patients with CML-AP or BC. 2 of them with low level (<2 x 10(-2)) survived without relapse, the other 2 case with high level (>2 x 10(-2)) relapsed within one year, 1 case died and 1 case received the second time HSCT, CML28 level decreased rapidly after HSCT, but still higher than 2 x 10(-2) and relapse has taken place. The conclusions was made that CML28 mRNA level is obviously correlated with the development of leukemia. Serial quantification of CML28 mRNA levels are necessary for HSCT recipients, and more informative than a single detection. Using of this assay to evaluate MRD in the patients received HSCT is helpful for prediction of relapse.


Asunto(s)
Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Antígenos de Neoplasias , Genética , Antígenos de Superficie , Genética , Exorribonucleasas , Genética , Complejo Multienzimático de Ribonucleasas del Exosoma , Trasplante de Células Madre Hematopoyéticas , Leucemia , Genética , Patología , Cirugía General , Recurrencia Local de Neoplasia , Compuestos Orgánicos , Química , ARN Mensajero , Genética , Proteínas de Unión al ARN , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Métodos , Factores de Tiempo
6.
Artículo en Inglés | WPRIM | ID: wpr-356499

RESUMEN

This study was aimed to construct nucleic acid vaccine containing the coding region of the CML28 gene and to express it in human dendritic cells. The full length of CML28 cDNA was amplified from K562 by RT-PCR and subcloned into pGEM-T vector. The CML28 fragment was digested and subsequently inserted into the EcoRI-Xba I sites of pcDNA3.1HisA to construct the recombinant expression vector pcDNA3.1HisA-CML28, which was identified by restrition analysis and sequencing. Human dendritic cells (DC) were separated from peripheral blood mononuclear cells (PBMC) by culture with rhGM-CSF, rhIL-4 and assessed by flow cytometry. The constructed plasmid pcDNA3.1 HisA-CML28 was transfected into DC by electroporation. Western blot was used to detect the expression of fusion protein His-CML28. The results showed that recombinant plasmid pcDNA3.1HisA-CML28 contained the correct full CML28 cDNA identified by restriction analysis and sequencing, and can express the fusion protein His-CML28 in DCs. It is concluded that nucleic acid vaccine containing CML28 gene was constructed and expressed in DC successfully.


Asunto(s)
Humanos , Antígenos de Neoplasias , Genética , Alergia e Inmunología , Metabolismo , Antígenos de Superficie , Genética , Alergia e Inmunología , Metabolismo , Western Blotting , Células Cultivadas , Clonación Molecular , ADN Complementario , Genética , Células Dendríticas , Biología Celular , Alergia e Inmunología , Metabolismo , Electroforesis en Gel de Poliacrilamida , Exorribonucleasas , Genética , Alergia e Inmunología , Metabolismo , Complejo Multienzimático de Ribonucleasas del Exosoma , Citometría de Flujo , Vectores Genéticos , Genética , Células K562 , Proteínas de Unión al ARN , Proteínas Recombinantes de Fusión , Genética , Alergia e Inmunología , Transfección , Métodos , Vacunas de ADN , Genética , Alergia e Inmunología
7.
Indian J Exp Biol ; 2004 Aug; 42(8): 808-11
Artículo en Inglés | IMSEAR | ID: sea-63113

RESUMEN

Effect of repeated (20 days) exposure to picrotoxin (PTX) on rat liver lysosomal function was evaluated by measuring the free and total activities of acid phosphatase, cathepsin D, ribonuclease II (RNAse II) and deoxyribonuclease II (DNAse II). The free activities of the nucleases (both RNAse II and DNAse II) were increased following PTX exposure. The total DNAse II activity was increased by 2.2-fold whereas the total acid phosphatase activity was decreased by 28%. Consequently, the ratios of total activity / free activity were low in the PTX exposed groups, implying loss of membrane integrity. Cathepsin D activity was completely abolished. The results show that repeated exposure to PTX can lead to lysosomal dysfunction in liver.


Asunto(s)
Fosfatasa Ácida/metabolismo , Animales , Catepsina D/metabolismo , Convulsivantes/administración & dosificación , Endodesoxirribonucleasas/metabolismo , Exorribonucleasas/metabolismo , Inyecciones Intraperitoneales , Hígado/efectos de los fármacos , Lisosomas/efectos de los fármacos , Masculino , Picrotoxina/administración & dosificación , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA